Your browser doesn't support javascript.
loading
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.
Hernandez, Nicholas; Bucciol, Giorgia; Moens, Leen; Le Pen, Jérémie; Shahrooei, Mohammad; Goudouris, Ekaterini; Shirkani, Afshin; Changi-Ashtiani, Majid; Rokni-Zadeh, Hassan; Sayar, Esra Hazar; Reisli, Ismail; Lefevre-Utile, Alain; Zijlmans, Dick; Jurado, Andrea; Pholien, Ruben; Drutman, Scott; Belkaya, Serkan; Cobat, Aurelie; Boudewijns, Robbert; Jochmans, Dirk; Neyts, Johan; Seeleuthner, Yoann; Lorenzo-Diaz, Lazaro; Enemchukwu, Chibuzo; Tietjen, Ian; Hoffmann, Hans-Heinrich; Momenilandi, Mana; Pöyhönen, Laura; Siqueira, Marilda M; de Lima, Sheila M Barbosa; de Souza Matos, Denise C; Homma, Akira; Maia, Maria de Lourdes S; da Costa Barros, Tamiris Azamor; de Oliveira, Patricia Mouta Nunes; Mesquita, Emersom Ciclini; Gijsbers, Rik; Zhang, Shen-Ying; Seligman, Stephen J; Abel, Laurent; Hertzog, Paul; Marr, Nico; Martins, Reinaldo de Menezes; Meyts, Isabelle; Zhang, Qian; MacDonald, Margaret R; Rice, Charles M; Casanova, Jean-Laurent; Jouanguy, Emmanuelle; Bossuyt, Xavier.
Afiliação
  • Hernandez N; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY.
  • Bucciol G; Laboratory of Inborn Errors of Immunity, Department of Immunology, Microbiology and Transplantation, KU Leuven, Leuven, Belgium.
  • Moens L; Laboratory of Inborn Errors of Immunity, Department of Immunology, Microbiology and Transplantation, KU Leuven, Leuven, Belgium.
  • Le Pen J; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • Shahrooei M; Specialized Immunology Laboratory of Dr. Shahrooei, Sina Medical Complex, Ahvaz, Iran.
  • Goudouris E; Department of Microbiology and Immunology, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.
  • Shirkani A; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Changi-Ashtiani M; Allergy and Clinical Immunology Department, Bushehr University of Medical Science, School of Medicine, Bushehr, Iran.
  • Rokni-Zadeh H; School of Mathematics, Institute for Research in Fundamental Sciences, Tehran, Iran.
  • Sayar EH; Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Reisli I; Department of Pediatrics, Division of Pediatric Immunology and Allergy, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey.
  • Lefevre-Utile A; Department of Pediatrics, Division of Pediatric Immunology and Allergy, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey.
  • Zijlmans D; Pediatrics Department, Jean Verdier Hospital, Assistance Publique des Hôpitaux de Paris, Paris 13 University, Bondy, France.
  • Jurado A; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • Pholien R; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • Drutman S; Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Belkaya S; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY.
  • Cobat A; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY.
  • Boudewijns R; Pediatric Immunology-Hematology Unit, Assistance Publique-Hôpitaux de Paris, Necker Hospital for Sick Children, Paris, France.
  • Jochmans D; Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Neyts J; Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Seeleuthner Y; Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Lorenzo-Diaz L; Paris Descartes University, Imagine Institute, Paris, France.
  • Enemchukwu C; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.
  • Tietjen I; Paris Descartes University, Imagine Institute, Paris, France.
  • Hoffmann HH; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.
  • Momenilandi M; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • Pöyhönen L; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • Siqueira MM; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • de Lima SMB; Specialized Immunology Laboratory of Dr. Shahrooei, Sina Medical Complex, Ahvaz, Iran.
  • de Souza Matos DC; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY.
  • Homma A; National Reference Laboratory for Respiratory Viruses, Institute Oswaldo Cruz, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
  • Maia MLS; Laboratory of Virological Techniques, Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
  • da Costa Barros TA; Laboratory of Immunological Techniques, Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
  • de Oliveira PMN; Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
  • Mesquita EC; Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
  • Gijsbers R; Laboratory of Immunological Techniques, Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
  • Zhang SY; Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
  • Seligman SJ; Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
  • Abel L; Laboratory for Viral Vector Technology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Hertzog P; Leuven Viral Vector Core, Leuven, Belgium.
  • Marr N; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY.
  • Martins RM; Paris Descartes University, Imagine Institute, Paris, France.
  • Meyts I; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.
  • Zhang Q; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY.
  • MacDonald MR; Department of Microbiology and Immunology, New York Medical College, Valhalla, NY.
  • Rice CM; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY.
  • Casanova JL; Paris Descartes University, Imagine Institute, Paris, France.
  • Jouanguy E; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.
  • Bossuyt X; Hudson Institute of Medical Research, Clayton, Victoria, Australia.
J Exp Med ; 216(9): 2057-2070, 2019 09 02.
Article em En | MEDLINE | ID: mdl-31270247
ABSTRACT
Vaccination against measles, mumps, and rubella (MMR) and yellow fever (YF) with live attenuated viruses can rarely cause life-threatening disease. Severe illness by MMR vaccines can be caused by inborn errors of type I and/or III interferon (IFN) immunity (mutations in IFNAR2, STAT1, or STAT2). Adverse reactions to the YF vaccine have remained unexplained. We report two otherwise healthy patients, a 9-yr-old boy in Iran with severe measles vaccine disease at 1 yr and a 14-yr-old girl in Brazil with viscerotropic disease caused by the YF vaccine at 12 yr. The Iranian patient is homozygous and the Brazilian patient compound heterozygous for loss-of-function IFNAR1 variations. Patient-derived fibroblasts are susceptible to viruses, including the YF and measles virus vaccine strains, in the absence or presence of exogenous type I IFN. The patients' fibroblast phenotypes are rescued with WT IFNAR1 Autosomal recessive, complete IFNAR1 deficiency can result in life-threatening complications of vaccination with live attenuated measles and YF viruses in previously healthy individuals.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina contra Sarampo / Vacina contra Febre Amarela / Padrões de Herança / Receptor de Interferon alfa e beta Limite: Adolescent / Child / Female / Humans / Infant / Male Idioma: En Revista: J Exp Med Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina contra Sarampo / Vacina contra Febre Amarela / Padrões de Herança / Receptor de Interferon alfa e beta Limite: Adolescent / Child / Female / Humans / Infant / Male Idioma: En Revista: J Exp Med Ano de publicação: 2019 Tipo de documento: Article